Content begins here

Peter L. Anderson, PharmD

Pharmacology Specialty Lab Co-Director

Dr. Anderson is Professor of Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus. His research interests are in the clinical pharmacology of antiHIV medications with a focus on pharmacological approaches to monitor medication adherence. He is coPrincipal Investigator of the Colorado Antiviral Pharmacology Laboratory, which is CLIA certified and provides assay support for NIHsupported national and international trial networks and independent multinational clinical trials. Dr. Anderson directed the pharmacology support and adherence interpretation for iPrEx, an international trial of Truvada for HIV chemoprophylaxis (PrEP) in men who have sex with men (MSM). This trial was one of two that led to approval of Truvada for PrEP. The lab also supported the DISCOVER study, a regulatory trial of Truvada versus Descovy for PrEP in MSM.